BMS Exempts New Mexico CHCs from CP Restrictions and Claims Data Reqs, Adds Drug to Policy September 29, 2026 Shannon Young, Managing Editor 340B Report Views BMS recently updated its 340B restrictions to exempt a new state and add a new drug. … Share this on: Read More »
Merck is 16th Drugmaker to Add 340B In-House Pharmacy Data Reqs September 24, 2026 William Newton 340B Report Views Merck said Wednesday it will soon require 340B hospitals and health centers to submit in-house pharmacy claims data in order to access 340B pricing. … Share this on: Read More »
Lilly Asks Fed Court to Dismiss Florida Hospital’s 340B Claims Data Suit September 24, 2026 William Newton, Editor-in-Chief 340B Report Views Eli Lilly recently asked a federal court to dismiss Tampa General Hospital's lawsuit over Lilly's 340B in-house pharmacy claims data requirements. … Share this on: Read More »
Most States Participating in Pilot to Lower Medicaid Drug Spending, CMS Says September 24, 2026 Shannon Young, Managing Editor 340B Report Views CMS announced that 40 states plus Puerto Rico have signed participation agreements for the administration’s GENEROUS Model on Sept. 18. … Share this on: Read More »
Hospitals, Drugmakers Support CMS’ 340B Data Repository, But Differ on Implementation September 22, 2026 William Newton, Editor-in-Chief 340B Report Views Hospitals and pharmaceutical industry groups recently submitted public comments on a CMS proposal to require mandatory 340B data repository reporting. … Share this on: Read More »
Fed Appeals Court Holds High-Stakes Hearing on Oklahoma’s 340B Law September 22, 2026 William Newton, Editor-in-Chief 340B Report Views A Denver, Colorado federal appeals court recently held oral arguments on Oklahoma's 340B contract pharmacy access law. … Share this on: Read More »
Fed Appeals Court Denies Novartis’ Bid to Rehear Missouri 340B Case September 22, 2026 William Newton, Editor-in-Chief 340B Report Views The U.S. 8th Circuit Court of Appeals will not reconsider its prior decision in favor of Missouri's 340B law. … Share this on: Read More »
4 Drugmakers to Refund CEs, 1 Announces NDC Change September 22, 2026 Shannon Young, Managing Editor 340B Report Views Four drugmakers announced 340B refunds to covered entities, while another unveiled a change to the NDC for a 340B-priced drug. … Share this on: Read More »
Fed Appeals Court Questions Drugmakers’ Bid to Intervene in Old 340B Rebate Lawsuit September 17, 2026 William Newton, Editor-in-Chief 340B Report Views Drug manufacturers asked a Boston federal appeals court to rule that they should have been allowed to intervene in a prior 340B rebate pilot suit. … Share this on: Read More »
Fed Judge Denies AbbVie’s Bid to Block New Mexico’s 340B Access Law September 17, 2026 William Newton, Editor-in-Chief 340B Report Views A federal judge denied AbbVie's request to temporarily block New Mexico's 340B law. … Share this on: Read More »
